Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1637 1681
This examiner grants 45% of resolved cases
Angela Marie Bertagna is an examiner in Tech Center 1600 and Art Unit 1637 with 711 resolved cases. Her allowance rate is 44.7 percent, and the median days to allowance is 1416. These metrics provide a statistical basis for observations within the 1600 tech center. The 1416-day median is a benchmark for the duration of the 711 cases she has handled.
The interview lift of 46.3 percent is a significant figure compared to the 44.7 percent allowance rate. This suggests that interviews are an effective tool for improving the probability of a grant. For the 711 cases resolved, the 1416-day median pendency highlights the importance of using the 46.3 percent lift to reach a resolution. The contrast between the allowance rate and the lift is a key feature of her profile. Practitioners should consider an interview given this 46.3 percent lift. The 1416-day median pendency remains a factor for any applicant.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18220183 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | Final Rejection | Natera, Inc. |
| 17986339 | BORDETELLA DETECTION ASSAY | Final Rejection | Quest Diagnostics Investments LLC |
| 18323079 | ENHANCING SPECIFICITY OF ANALYTE BINDING | Non-Final OA | 10x Genomics, Inc. |
| 18196835 | NANO-PARTITIONS FOR MULTIPLE REACTIONS IN PARTITION-BASED ASSAYS | Non-Final OA | 10x Genomics, Inc. |
| 17920379 | UNIVERSAL PRIMERS FOR DETECTION OF BACTERIA, FUNGI AND EUKARYOTIC MICROORGANISMS | Non-Final OA | The Regents of the University of California |
| 18637935 | Reagents and Methods for Detecting HCV | Non-Final OA | Siemens Healthcare Diagnostics Inc. |
| 17401662 | Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same | Final Rejection | Takara Bio USA, Inc. |
| 18459672 | METHODS FOR DETERMINING A NUCLEOTIDE SEQUENCE CONTIGUOUS TO A KNOWN TARGET NUCLEOTIDE SEQUENCE | Non-Final OA | THE GENERAL HOSPITAL CORPORATION |
| 17360121 | DETECTION OF BACTERIAL (MOLLICUTIES) CONTAMINATION | Final Rejection | Roche Diagnostics Operations, Inc. |
| 18693441 | Rolling Circle Amplification-Coupled Glass Nanopore Counting of Mild Traumatic Brain Injury-Related Salivary miRNAs | Non-Final OA | THE PENN STATE RESEARCH FOUNDATION |
| 18003412 | AMPLICON COMPREHENSIVE ENRICHMENT | Final Rejection | William Marsh Rice University |
| 18027971 | MULTIPLEX NUCLEIC ACID DETECTION METHOD, COMPOSITION AND KIT | Final Rejection | MACCURA BIOTECHNOLOGY CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy